Security key
88338N107
- Security type / class
- Equity / COM
- Total 13F shares
- 152,335,132
- Total 13F value
- $190,408,846
- Share change
- -30,575,536
- Put/Call ratio
- 182%
- SEC-reported price per share
- $1.25
- Number of holders
- 142
- Value change
- -$36,023,732
- Number of buys
- 68
- Number of sells
- 53
Open additional details 1 more signal available
Report period
Q2 2020
Institutions
142
Top holders
10
TXMD full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2020
Previous quarter: Q1 2020
TherapeuticsMD, Inc. SEC filings
TherapeuticsMD, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 88338N107
Recent filing periods:
Ownership snapshot
Top reported holders of TXMD - THERAPEUTICSMD INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
0/15
Latest evidence
31 Mar 2020
13F
Highest disclosed value: $20,522,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
PRICE T ROWE ASSOCIATES INC /MD/ has the largest disclosed position value at $20.52M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Disclosed position value
Top 5
PRICE T ROWE ASSOCIATES INC /MD/
$20.52M
JPMORGAN CHASE & CO
$20.44M
BlackRock Finance, Inc.
$19.01M
VANGUARD GROUP INC
$18.01M
FMR LLC
$17.67M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
—
class O/S missing
|
$20,522,000
19,360,547 shares
|
— | 31 Mar 2020 |
| JPMORGAN CHASE & CO |
13F
Company
|
—
class O/S missing
|
$20,435,000
19,278,590 shares
|
— | 31 Mar 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
—
class O/S missing
|
$19,014,000
17,938,096 shares
|
— | 31 Mar 2020 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$18,008,000
16,989,962 shares
|
— | 31 Mar 2020 |
| FMR LLC |
13F
Company
|
—
class O/S missing
|
$17,666,000
16,666,018 shares
|
— | 31 Mar 2020 |
| Bank of New York Mellon Corp |
13F
Company
|
—
class O/S missing
|
$13,442,000
12,681,255 shares
|
— | 31 Mar 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
142
Shares
152,335,132
Rows available
142
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
135
Q2 2020 holders
142
Holder diff
7
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 value | Q2 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend